BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37739137)

  • 1. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE.
    Elziny S; Crino PB; Winawer M
    Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE).
    Bonduelle T; Hartlieb T; Baldassari S; Sim NS; Kim SH; Kang HC; Kobow K; Coras R; Chipaux M; Dorfmüller G; Adle-Biassette H; Aronica E; Lee JH; Blumcke I; Baulac S
    Acta Neuropathol Commun; 2021 Jan; 9(1):3. PubMed ID: 33407896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.
    Najm I; Lal D; Alonso Vanegas M; Cendes F; Lopes-Cendes I; Palmini A; Paglioli E; Sarnat HB; Walsh CA; Wiebe S; Aronica E; Baulac S; Coras R; Kobow K; Cross JH; Garbelli R; Holthausen H; Rössler K; Thom M; El-Osta A; Lee JH; Miyata H; Guerrini R; Piao YS; Zhou D; Blümcke I
    Epilepsia; 2022 Aug; 63(8):1899-1919. PubMed ID: 35706131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal cortical dysplasia: Updates.
    Pinheiro J; Honavar M
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S189-S197. PubMed ID: 35562149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal cortical dysplasia: a practical guide for neurologists.
    Balestrini S; Barba C; Thom M; Guerrini R
    Pract Neurol; 2023 Aug; 23(4):293-302. PubMed ID: 36823117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinical characteristics and histopathological transcription in 40 patients afflicted by epilepsy stemming from focal cortical dysplasia.
    Zhang K; Yao H; Yang J; Jia T; Shan Q; Li D; Li M; Gan L; Wang X; Dong Y
    Epilepsia Open; 2024 Jun; 9(3):981-995. PubMed ID: 38491953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis.
    Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B
    Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.
    Winawer MR; Griffin NG; Samanamud J; Baugh EH; Rathakrishnan D; Ramalingam S; Zagzag D; Schevon CA; Dugan P; Hegde M; Sheth SA; McKhann GM; Doyle WK; Grant GA; Porter BE; Mikati MA; Muh CR; Malone CD; Bergin AMR; Peters JM; McBrian DK; Pack AM; Akman CI; LaCoursiere CM; Keever KM; Madsen JR; Yang E; Lidov HGW; Shain C; Allen AS; Canoll PD; Crino PB; Poduri AH; Heinzen EL
    Ann Neurol; 2018 Jun; 83(6):1133-1146. PubMed ID: 29679388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging findings and clinical characteristics in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy in a predominantly adult cohort.
    Mendes Coelho VC; Morita-Sherman M; Yasuda CL; Alvim MMK; Amorim BJ; Tedeschi H; Ghizoni E; Rogerio F; Cendes F
    Epilepsia; 2021 Jun; 62(6):1429-1441. PubMed ID: 33884614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
    Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
    Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of somatic mutational events in the pathogenesis of epilepsy.
    Iffland PH; Crino PB
    Curr Opin Neurol; 2019 Apr; 32(2):191-197. PubMed ID: 30762606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations involving TSC 1 and TSC2 genes in two children with focal cortical dysplasia.
    Jha R; Kurup A; Kovilapu UB; Ranjan R; Sondhi V
    Brain Dev; 2022 Feb; 44(2):166-172. PubMed ID: 34756499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE): a widespread disease with an apparently focal epilepsy.
    Seetharam R; Nooraine J; Mhatre R; Ramachandran J; Iyer RB; Mahadevan A
    Epileptic Disord; 2021 Apr; 23(2):407-411. PubMed ID: 33935026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
    Mühlebner A; Coras R; Kobow K; Feucht M; Czech T; Stefan H; Weigel D; Buchfelder M; Holthausen H; Pieper T; Kudernatsch M; Blümcke I
    Acta Neuropathol; 2012 Feb; 123(2):259-72. PubMed ID: 22120580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative ultrasonography (ioUS) characteristics of focal cortical dysplasia (FCD) type II b.
    Prada F; Gennari AG; Del Bene M; Bono BC; Quaia E; D'Incerti L; Villani F; Didato G; Tringali G; DiMeco F
    Seizure; 2019 Jul; 69():80-86. PubMed ID: 30999253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of brain somatic variation in epilepsy-associated developmental lesions.
    Bedrosian TA; Miller KE; Grischow OE; Schieffer KM; LaHaye S; Yoon H; Miller AR; Navarro J; Westfall J; Leraas K; Choi S; Williamson R; Fitch J; Kelly BJ; White P; Lee K; McGrath S; Cottrell CE; Magrini V; Leonard J; Pindrik J; Shaikhouni A; Boué DR; Thomas DL; Pierson CR; Wilson RK; Ostendorf AP; Mardis ER; Koboldt DC
    Epilepsia; 2022 Aug; 63(8):1981-1997. PubMed ID: 35687047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS; Kim WI; Kang HC; Kim SH; Park AH; Park EK; Cho YW; Kim S; Kim HM; Kim JA; Kim J; Rhee H; Kang SG; Kim HD; Kim D; Kim DS; Lee JH
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.